[Federal Register Volume 60, Number 234 (Wednesday, December 6, 1995)]
[Notices]
[Page 62477]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-29675]



-----------------------------------------------------------------------


DEPARTMENT OF JUSTICE

Notice Pursuant to the National Cooperative Research and 
Production Act of 1993--Continuous Biocatalytic Systems for the 
Production of Chemicals From Renewable Resources

    Notice is hereby given that, on September 15, 1995, pursuant to 
Section 6(a) of the National Cooperative Research and Production Act of 
1993, 15 U.S.C. Sec. 4301 et seq. (``the Act''), Genencor 
International, Inc. filed notifications simultaneously with the 
Attorney General and the Federal Trade Commission disclosing (1) the 
identities of the parties to and (2) the nature and objectives of the 
joint venture. The notifications were filed for the purpose of invoking 
the Act's provisions limiting the recovery of antitrust plaintiffs to 
actual damages under specified circumstances. Pursuant to Section 6(b) 
of the Act, the identities of the parties to the joint venture are 
Genencor International, Inc., Rochester, NY; Eastman Chemical Company, 
Kingsport, TN; ElectroSynthesis Company, Inc., Lancaster, NY; 
MicroGenomics, Inc., Somerville, NJ; and Argonne National laboratory, 
Argonne, IL. The objective of the joint venture is to explore 
economically viable biocatalytic systems for the production of various 
chemicals from renewable agricultural resources, including corn and 
other carbohydrate-rich plant materials. The biocatalytic systems are 
intended to be continuous as opposed to the more costly batch mode 
currently employed in biocatalysis, significantly reducing the amount 
of time required to achieve competitive process economics. If 
successful, the project could result in reducing the nation's reliance 
on imported petroleum and benefiting the U.S. chemical and chemical-
consuming industries.
Constance, K. Robinson,
Director of Operations, Antitrust Division.
[FR Doc. 95-29675 Filed 12-5-95; 8:45 am]
BILLING CODE 4410-01-M